Extracapsular spread (ECS) is one of the most important prognostic factors in head and neck
squamous cell carcinoma (HNSCC). However, despite its major clinical relevance, there are …

Squamous cell carcinoma of the oral cavity and oropharynx have been used synonymously
and interchangeably in the world literature in the context of head and neck cancers. As the …

PURPOSE The aim of the current work is to provide evidence-based recommendations to
practicing physicians and others on the management of the neck in patients with squamous …

Background An objective definition of clinically relevant extracapsular nodal spread (ECS) in
head and neck squamous cell carcinoma (SCC) is unavailable. Methods Pathologic review …

BACKGROUND: Extracapsular spread (ECS) is commonly used to justify adjuvant
chemotherapy in patients with head and neck cancer. The role of ECS as a prognosticator …

BACKGROUND Extracapsular spread (ECS) in cervical lymph node metastases from head
and neck squamous cell carcinoma (SCC) is regarded as an adverse prognostic factor and …

BACKGROUND Extranodal (or extracapsular) extension (ENE) is an adverse prognostic
factor in patients with head and neck cancers who undergo primary surgery. However, the …

Purpose The purpose of our study is to determine the rate of detectability of ctHPVDNA after
surgery but before adjuvant therapy in patients with human papillomavirus (HPV)-associated …

Background Due to unique biology and prognosis, precise identification of predictive
parameters is critical for p16+ oropharyngeal squamous cell carcinoma (OPSCC). Prior …

Abstract Objectives/Hypothesis: Current head and neck epidemiology demonstrates a
steadily increasing incidence of p16+ human papillomavirus‐related oropharynx squamous …